Tag: Patient Advocacy
Co Kilkenny Woman Takes Legal Action Against HSE for Access to...
A 28-year-old woman from County Kilkenny is suing the Health Service Executive (HSE) over her denied access to a crucial drug for treating her rare condition, Friedreich's ataxia.
Co Kilkenny Woman Sues HSE Over Access to Life-Changing Drug for...
A 28-year-old woman from County Kilkenny is taking legal action against the Health Service Executive (HSE) to gain access to a critical drug that could significantly impact her life, as she battles the rare condition known as Friedreich's ataxia.
Urgent Call for Care Pathway for Huntington’s Disease Patients in Ireland
A recent ruling emphasizes the critical need for a structured care pathway for patients suffering from Huntington's disease. This article explores the implications and urgency of the situation.
Urgent Call for Comprehensive Care Pathway for Huntington’s Disease Patients
A recent ruling emphasizes the critical need for a structured care pathway for Huntington's disease patients, highlighting the importance of timely support and resources.
Urgent Need for Care Pathway for Huntington’s Disease Patients, Says Judge
A recent ruling emphasizes the critical need for a structured care pathway for patients suffering from Huntington’s disease, highlighting the urgent response required to support affected families.
Taoiseach Acknowledges Communication Challenges in Rare Drugs Reimbursement Process
In a recent address, the Taoiseach highlighted ongoing communication issues affecting the reimbursement process for rare drugs in Ireland, emphasizing the need for improvements.
Taoiseach Acknowledges Communication Challenges in Rare Drug Reimbursement Process
The Taoiseach has admitted to issues in the communication surrounding the reimbursement process for rare drugs, highlighting the need for improvement in the system.
Taoiseach Acknowledges Communication Challenges in Rare Drugs Reimbursement Process
In a recent statement, Taoiseach confirms communication issues surrounding Ireland's reimbursement process for rare medications, emphasizing the need for better clarity and efficiency.
Taoiseach Acknowledges Communication Challenges in Rare Drug Reimbursement Process
In a recent statement, the Taoiseach has recognized ongoing communication issues surrounding the reimbursement process for rare drugs, highlighting the need for improvements in transparency and efficiency.
Taoiseach Acknowledges Communication Problems in Rare Drugs Reimbursement Process
In a recent statement, the Taoiseach accepted that there are significant communication issues surrounding the reimbursement process for rare drugs in Ireland. This acknowledgment comes amidst growing concerns from patients and advocates.
